317. Trifunctional protein deficiency Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 4 / Drugs : 9 - (DrugBank : 4) / Drug target gene : 1 - Drug target pathway : 1
Trifunctional protein deficiency and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
ID | Diseases (Sorted by drug repositionability) |
---|---|
317 | Trifunctional protein deficiency |
13 | Multiple sclerosis/Neuromyelitis optica |
299 | Cystic fibrosis |
46 | Malignant rheumatoid arthritis |
51 | Scleroderma |
60 | Aplastic anemia |
84 | Sarcoidosis |
280 | Huge arteriovenous malformation with cervicofacial or limb lesion |
271 | Ankylosing spondylitis |
79 | Homozygous familial hypercholesterolemia |
107 | Juvenile idiopathic arthritis |
97 | Ulcerative colitis |
316 | Carnitine cycle disorder |
226 | Interstitial cystitis with Hunners ulcer |
70 | Spinal stenosis |
224 | Purpura nephritis |
288 | Autoimmune acquired coagulation factor deficiency |
47 | Buerger disease |